| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $266.7M | +24.0% |
| Cost of Revenue | $95.8M | +29.4% |
| R&D Expense | $265.9M | -7.2% |
| SG&A Expense | $281.6M | +8.7% |
| Operating Income | -$366.6M | +9.3% |
| Pre-tax Income | -$334.6M | +24.5% |
| Income Tax | $0 | — |
| Net Income | -$334.6M | +24.5% |
| EPS (Basic) | -$0.35 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $790.2M | -21.6% |
| Short-term Investments | $16.3M | — |
| Accounts Receivable | $59.2M | +48.1% |
| Inventory | $44.8M | +41.8% |
| Current Assets | $939.6M | -16.4% |
| Total Assets | $1.04B | -15.1% |
| Current Liabilities | $203.1M | +45.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$198.2M | +46.1% |
| Capital Expenditures | $7.2M | -70.7% |
| Investing Cash Flow | -$10.8M | -102.6% |
| Financing Cash Flow | -$6.4M | -271.8% |
| Free Cash Flow | -$205.4M | +47.6% |
| +23.9% |
| EPS (Diluted) | -$0.35 | +23.9% |
| Total Liabilities |
| $240.2M |
| +37.6% |
| Stockholders' Equity | $796.1M | -23.9% |